What does DexCom, Inc. do?
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose…
What is DexCom, Inc.'s P/E and P/B ratio?
DexCom, Inc. has a P/E ratio of 30.9 and a P/B ratio of 11.22.
What is DexCom, Inc.'s debt-to-equity ratio?
DexCom, Inc. has a debt-to-equity ratio of 0.53.
How much does DexCom, Inc. owe compared with what it owns?
DexCom, Inc. owes $0.59 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is DexCom, Inc.'s Positivity rank?
DexCom, Inc. is ranked #5,773 of 6,775 companies globally and #3,200 of 4,000 in United States on PositoAI, with a Positivity Score of 15,627.
Does DexCom, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for DexCom, Inc..
Where can I read the latest news about DexCom, Inc.?
Recent headlines about DexCom, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does DexCom, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of DexCom, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.